INSP logo

Inspire Medical Systems, Inc. (INSP) EBITDA

Annual EBITDA:

$65.03M+$82.08M(+481.15%)
December 31, 2024

Summary

  • As of today, INSP annual EBITDA is $65.03 million, with the most recent change of +$82.08 million (+481.15%) on December 31, 2024.
  • During the last 3 years, INSP annual EBITDA has risen by +$103.65 million (+268.35%).
  • INSP annual EBITDA is now at all-time high.

Performance

INSP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSPincome statement metrics

Quarterly EBITDA:

$98.00K-$1.46M(-93.71%)
June 30, 2025

Summary

  • As of today, INSP quarterly EBITDA is $98.00 thousand, with the most recent change of -$1.46 million (-93.71%) on June 30, 2025.
  • Over the past year, INSP quarterly EBITDA has dropped by -$6.38 million (-98.49%).
  • INSP quarterly EBITDA is now -99.71% below its all-time high of $34.36 million, reached on December 31, 2024.

Performance

INSP Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSPincome statement metrics

TTM EBITDA:

$52.19M-$6.38M(-10.90%)
June 30, 2025

Summary

  • As of today, INSP TTM EBITDA is $52.19 million, with the most recent change of -$6.38 million (-10.90%) on June 30, 2025.
  • Over the past year, INSP TTM EBITDA has increased by +$63.26 million (+571.43%).
  • INSP TTM EBITDA is now -10.90% below its all-time high of $58.57 million, reached on March 31, 2025.

Performance

INSP TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSPincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

INSP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+481.1%-98.5%+571.4%
3Y3 Years+268.4%+100.7%+232.9%
5Y5 Years+312.6%+100.4%+191.6%

INSP EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+259.6%-99.7%+100.5%-10.9%+204.0%
5Y5-Yearat high+220.1%-99.7%+100.5%-10.9%+191.6%
All-TimeAll-Timeat high+220.1%-99.7%+100.4%-10.9%+191.6%

INSP EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$98.00K(-93.7%)
$52.19M(-10.9%)
Mar 2025
-
$1.56M(-95.5%)
$58.57M(+37.4%)
Dec 2024
$65.03M(+481.2%)
$34.36M(+112.5%)
$42.63M(+131.9%)
Sep 2024
-
$16.17M(+149.4%)
$18.39M(+266.1%)
Jun 2024
-
$6.48M(+145.1%)
-$11.07M(+66.6%)
Mar 2024
-
-$14.38M(-242.2%)
-$33.16M(+11.4%)
Dec 2023
-$17.06M(+58.1%)
$10.11M(+176.1%)
-$37.42M(+20.4%)
Sep 2023
-
-$13.29M(+14.9%)
-$47.04M(+6.2%)
Jun 2023
-
-$15.61M(+16.2%)
-$50.18M(-4.8%)
Mar 2023
-
-$18.64M(-3858.1%)
-$47.90M(-7.2%)
Dec 2022
-$40.73M(-5.5%)
$496.00K(+103.0%)
-$44.69M(+3.7%)
Sep 2022
-
-$16.42M(-23.2%)
-$46.41M(-18.2%)
Jun 2022
-
-$13.33M(+13.6%)
-$39.27M(-3.3%)
Mar 2022
-
-$15.44M(-1170.5%)
-$38.01M(-0.4%)
Dec 2021
-$38.62M(+28.6%)
-$1.22M(+86.9%)
-$37.86M(+12.4%)
Sep 2021
-
-$9.29M(+23.0%)
-$43.23M(+0.3%)
Jun 2021
-
-$12.07M(+21.0%)
-$43.38M(+19.2%)
Mar 2021
-
-$15.28M(-132.3%)
-$53.68M(+1.3%)
DateAnnualQuarterlyTTM
Dec 2020
-$54.13M(-77.0%)
-$6.58M(+30.3%)
-$54.41M(+4.5%)
Sep 2020
-
-$9.44M(+57.8%)
-$56.97M(-1.6%)
Jun 2020
-
-$22.38M(-39.8%)
-$56.05M(-34.3%)
Mar 2020
-
-$16.01M(-75.2%)
-$41.74M(-21.3%)
Dec 2019
-$30.59M(-68.7%)
-$9.14M(-7.3%)
-$34.40M(-14.5%)
Sep 2019
-
-$8.52M(-5.6%)
-$30.05M(-15.2%)
Jun 2019
-
-$8.07M(+7.0%)
-$26.09M(-10.7%)
Mar 2019
-
-$8.67M(-81.0%)
-$23.55M(-17.9%)
Dec 2018
-$18.13M(-17.2%)
-$4.79M(-5.3%)
-$19.98M(-6.3%)
Sep 2018
-
-$4.55M(+17.9%)
-$18.80M(-5.8%)
Jun 2018
-
-$5.54M(-8.5%)
-$17.77M(-7.6%)
Mar 2018
-
-$5.11M(-41.4%)
-$16.51M(-6.7%)
Dec 2017
-$15.47M(+9.6%)
-$3.61M(-2.6%)
-$15.47M(-30.4%)
Sep 2017
-
-$3.52M(+17.7%)
-$11.86M(-42.2%)
Jun 2017
-
-$4.28M(-5.3%)
-$8.34M(-105.3%)
Mar 2017
-
-$4.06M
-$4.06M
Dec 2016
-$17.12M(+12.9%)
-
-
Dec 2015
-$19.65M
-
-

FAQ

  • What is Inspire Medical Systems, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Inspire Medical Systems, Inc.?
  • What is Inspire Medical Systems, Inc. annual EBITDA year-on-year change?
  • What is Inspire Medical Systems, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Inspire Medical Systems, Inc.?
  • What is Inspire Medical Systems, Inc. quarterly EBITDA year-on-year change?
  • What is Inspire Medical Systems, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Inspire Medical Systems, Inc.?
  • What is Inspire Medical Systems, Inc. TTM EBITDA year-on-year change?

What is Inspire Medical Systems, Inc. annual EBITDA?

The current annual EBITDA of INSP is $65.03M

What is the all-time high annual EBITDA for Inspire Medical Systems, Inc.?

Inspire Medical Systems, Inc. all-time high annual EBITDA is $65.03M

What is Inspire Medical Systems, Inc. annual EBITDA year-on-year change?

Over the past year, INSP annual EBITDA has changed by +$82.08M (+481.15%)

What is Inspire Medical Systems, Inc. quarterly EBITDA?

The current quarterly EBITDA of INSP is $98.00K

What is the all-time high quarterly EBITDA for Inspire Medical Systems, Inc.?

Inspire Medical Systems, Inc. all-time high quarterly EBITDA is $34.36M

What is Inspire Medical Systems, Inc. quarterly EBITDA year-on-year change?

Over the past year, INSP quarterly EBITDA has changed by -$6.38M (-98.49%)

What is Inspire Medical Systems, Inc. TTM EBITDA?

The current TTM EBITDA of INSP is $52.19M

What is the all-time high TTM EBITDA for Inspire Medical Systems, Inc.?

Inspire Medical Systems, Inc. all-time high TTM EBITDA is $58.57M

What is Inspire Medical Systems, Inc. TTM EBITDA year-on-year change?

Over the past year, INSP TTM EBITDA has changed by +$63.26M (+571.43%)
On this page